Citation Impact
Citing Papers
Intrarectal application of amifostine for the prevention of radiation-induced rectal injury
2002
Recent results of management of palpable clinically localized prostate cancer
1993
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Cancer Statistics, 2006
2006 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Epidemiology of Prostate Cancer
2019 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
Head and Neck Cancer
1993 Standout
Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations
2004 Standout
6Phytoestrogens and diseases of the prostate gland
1998
The Ki-67 protein: From the known and the unknown
2000 Standout
Lymphedema beyond breast cancer
2010 Standout
Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06
1988
Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients
2002 Standout
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
1997
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer
1995
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
BIOLOGICAL ACTIVITIES OF SOME PURINE ARABINOSIDES
1975 StandoutNobel
The sensitivity to bleomycin of a solid mouse tumour at different stages of growth
1974
Early Detection of Prostate Cancer
1989
Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
1997
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
1987 Standout
Changing role of chemotherapy in treatment of head and neck cancer
1982
Surgical palliation for pancreatic cancer: developments during the past two decades
1992
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.
1984
Cutaneous T Cell Lymphoma
1986
Identification of Residual Cancer in the Prostate Following Radiation Therapy: Role of Transrectal Ultrasound Guided Biopsy and Prostate Specific Antigen
1989
The role of radical prostatectomy in the management of prostatic cancer
1987
Thermal dose determination in cancer therapy
1984 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
The antitumor activities of flavonoids.
2005 Standout
SOME ASPECTS OF IMMUNOSUPPRESSION
1966 StandoutNobel
Attempted targeting of a monoclonal antibody in a human tumour xenograft system
1981 StandoutNobel
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 Standout
Pyogenic Vertebral Osteomyelitis: Report of Nine Cases and Review of the Literature
1979 Standout
Metabolic aspects of the role of hyperthermia im mammalian cell inactivation and their possible relevance to cancer treatment.
1974
Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma
1999
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
1970 Standout
Long-Term Results of Retropubic Permanent 125 Iodine Implantation of the Prostate for Clinically Localized Prostatic Cancer
1997
Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.
1981
Pyogenic vertebral osteomyelitis in heroin addicts.
1973
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
1988 Standout
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Metabolic Basis for the Actions of Analogs of Purines and Pyrimidines
1965 StandoutNobel
Complications Following External Beam Radiation Therapy for Prostate Cancer: An Analysis of Patients Treated with and without Staging Pelvic Lymphadenectomy
1991
Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels
1991
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated Patients
1989
THE CONTEMPORARY MANAGEMENT OF PROSTATE CANCER IN THE UNITED STATES: LESSONS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR (CAPSURE), A NATIONAL DISEASE REGISTRY
2004
Cultured Human Tumour Cells May Be Arrested In All Stages of the Cycle During Stationary Phase: Demonstration of Quiescent Cells In G1, S and G2 Phase
1984
The Radical Radiotherapy of Regionally Localized Hodgkin's Disease
1962
Consensus statement: Guidelines for PSA following radiation therapy1
1997 Standout
Works of Bagshaw Ma being referenced
The role of total skin irradiation with electrons in the management of mycosis fungoides.
1977
Medulloblastoma--treatment and prognosis. A study of seventeen cases in ten years.
1973
The Stanford medical linear accelerator. III. Application to clinical problems of radiation therapy.
1957
Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.
1974
Possible role of potentiators in radiation therapy.
1961
Radiotherapy of prostatic cancer: Stanford University experience.
1984
Status of radiation treatment of prostate cancer at Stanford University.
1988